Influence of Stem Cell Mobilization After Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Regimen in Patients with Newly Diagnosed Multiple Myeloma

被引：0
|
作者：
Ahn, Jae-Sook [1 ]
Yang, Deok-Hwan [1 ]
Jung, Sung-Hoon [1 ]
Bae, Soo-Young [1 ]
Kim, Yeo-Kyeoung [1 ]
Kim, Hyeoung-Joon [1 ]
Lee, Je-Jung [1 ]
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Jeollanam Do, South Korea
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：840 / 840
页数：1
相关论文
共 50 条
  • [31] Bortezomib and Thalidomide, a Steroid Free Regimen in Newly Diagnosed Patients with Multiple Myeloma
    Ghosh, Nilanjan
    Ferguson, Anna
    Ye, Xiaobu
    Huff, Carol A.
    Borrello, Ivan M.
    [J]. BLOOD, 2009, 114 (22) : 1119 - 1119
  • [32] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Meletios A Dimopoulos
    Efstathios Kastritis
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 690 - 691
  • [33] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 690 - 691
  • [34] Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma
    Dimopoulos, MA
    Hamilos, G
    Zomas, A
    Gika, D
    Efstathiou, E
    Grigoraki, V
    Poziopoulos, C
    Xilouri, I
    Zorzou, MP
    Anagnostopoulos, N
    Anagnostopoulos, A
    [J]. HEMATOLOGY JOURNAL, 2004, 5 (02) : 112 - 117
  • [35] Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results
    Morgan, Gareth J.
    Davies, Faith E.
    Gregory, Walter M.
    Bell, Sue E.
    Szubert, Alexander J.
    Coy, Nuria Navarro
    Cook, Gordon
    Feyler, Sylvia
    Johnson, Peter R. E.
    Rudin, Claudius
    Drayson, Mark T.
    Owen, Roger G.
    Ross, Fiona M.
    Russell, Nigel H.
    Jackson, Graham H.
    Child, J. Anthony
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 442 - 450
  • [36] Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield
    I Breitkreutz
    H M Lokhorst
    M S Raab
    B van der Holt
    F W Cremer
    D Herrmann
    A Glasmacher
    I G H Schmidt-Wolf
    I W Blau
    H Martin
    H Salwender
    A Haenel
    P Sonneveld
    H Goldschmidt
    [J]. Leukemia, 2007, 21 : 1294 - 1299
  • [37] Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield
    Breitkreutz, I.
    Lokhorst, H. M.
    Raab, M. S.
    van der Holt, B.
    Cremer, F. W.
    Herrmann, D.
    Glasmacher, A.
    Schmidt-Wolf, I. G. H.
    Blau, I. W.
    Martin, H.
    Salwender, H.
    Haenel, A.
    Sonneveld, P.
    Goldschmidt, H.
    [J]. LEUKEMIA, 2007, 21 (06) : 1294 - 1299
  • [38] Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients
    Palumbo, Antonio
    Bringhen, Sara
    Villani, Oreste
    Siniscalchi, Agostina
    Russo, Eleonora
    Uccello, Giuseppina
    Cerrato, Chiara
    Gilestro, Milena
    Rossi, Davide
    Boccadoro, Mario
    [J]. BLOOD, 2012, 120 (21)
  • [39] Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma
    Tuchman, Sascha A.
    Bacon, Wendi A.
    Huang, Li-Wen
    Long, Gwynn
    Rizzieri, David
    Horwitz, Mitchell
    Chute, John P.
    Sullivan, Keith
    Engemann, Ashley Morris
    Yopp, Amanda
    Li, Zhiguo
    Corbet, Kelly
    Chao, Nelson
    Gasparetto, Cristina
    [J]. JOURNAL OF CLINICAL APHERESIS, 2015, 30 (03) : 176 - 182
  • [40] CLNICAL EFFICACY OF VEL-CTD (BORTEZOMIB, CYCLOPHOSPHAMIDE, THALIDOMIDE, AND DEXAMETHASONE) REGIMEN IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: A PHASE II STUDY
    Kim, Y. K.
    Ahn, J. S.
    Yang, D. H.
    Sohn, S. K.
    Moon, J. H.
    Kim, H. J.
    Shin, H. J.
    Chung, J. S.
    Choi, Y. J.
    Chae, Y. S.
    Kim, J. G.
    Lee, J. H.
    Lee, J. J.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 383 - 383
12345